FDG PET/CT in the management of colorectal and anal cancers.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25341152.
- Also identified by DOI 10.2214/AJR.13.12256.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
CT remains the imaging modality of choice in the diagnosis of colorectal cancer (CRC) and anal cancer. However, advances in imaging have expanded the role of MRI and PET/CT. This article focuses on the evolving role of FDG PET/CT in the diagnosis, radiation therapy planning, therapy assessment, and posttherapy monitoring of CRC and anal cancer. FDG PET/CT is a valuable imaging modality that impacts the clinical management of patients with CRC and those with anal cancer.
Medical subject headings
- Anus Neoplasms
- Colorectal Neoplasms
- Fluorodeoxyglucose F18
- Multimodal Imaging
- Positron-Emission Tomography
- Tomography, X-Ray Computed